PT 141

Description

PT-141, also known as Bremelanotide, is a synthetic peptide derived from the melanocortin peptide family. Originally developed from Melanotan II, PT-141 was designed to selectively investigate the biological effects of melanocortin receptor activation, particularly within the central nervous system.

Researchers have studied PT-141 in both preclinical and clinical settings to better understand melanocortin receptor signalling, neuroendocrine physiology, and the regulation of sexual behaviour. Unlike Melanotan II, PT-141 exhibits minimal effects on skin pigmentation at research doses, making it a valuable tool for investigating central melanocortin pathways.

Areas of Scientific Interest

• Research has investigated PT-141 for its activation of melanocortin receptors involved in neuroendocrine signalling and central nervous system function.
• Clinical studies have examined its effects on sexual behaviour and physiological responses through central melanocortin pathways.
• Experimental research has explored the role of melanocortin receptor signalling in behavioural neuroscience, endocrine regulation, and autonomic physiology.
• Ongoing investigations continue to evaluate the broader biological functions of melanocortin receptor agonists in neuroscience and endocrinology.

Product Features

• High-purity lyophilised peptide
• Contains 10mg PT-141 (Bremelanotide)
• Manufactured for laboratory and scientific research
• Quality tested for identity and purity
• Securely packaged to help maintain product integrity

References

• Giuliano F, Allard J. Bremelanotide: From Melanocortin Receptor Agonist to Therapeutic Agent. European Urology.
• Diamond LE, Earle DC, Heiman JR, et al. An evaluation of the pharmacology and clinical research surrounding Bremelanotide. Journal of Sexual Medicine.
• Pfaus JG. Pathways of sexual desire and arousal: The role of melanocortin receptor agonists. CNS Drugs.